527 filings
8-K
TENX
Tenax Therapeutics Inc
18 Nov 20
Regulation FD Disclosure
4:17pm
10-Q
2020 Q3
TENX
Tenax Therapeutics Inc
Quarterly report
16 Nov 20
4:16pm
8-K
TENX
Tenax Therapeutics Inc
15 Oct 20
Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation
8:46am
424B3
TENX
Tenax Therapeutics Inc
1 Oct 20
Prospectus supplement
9:13am
EFFECT
TENX
Tenax Therapeutics Inc
1 Oct 20
Notice of effectiveness
12:15am
CORRESP
unf9gdj63bcb353
29 Sep 20
Correspondence with SEC
12:00am
CORRESP
514n x9345t
11 Sep 20
Correspondence with SEC
12:00am
4
zekm95xd
9 Sep 20
TENAX THERAPEUTICS / Steven Boyd ownership change
7:04pm
UPLOAD
dq62ndg4z2py psapsi7
4 Sep 20
Letter from SEC
12:00am
4
tcpnjovtlyji
3 Sep 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:39pm
4
snfoeje9
31 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
7:38pm
4
e5uzpuakr0s31el zhm1
26 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:47pm
4
zgr wlpbw1c
21 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:56pm
SC 13G/A
nfpqrm
7 Aug 20
TENAX THERAPEUTICS / BlackRock ownership change
12:00am
D
xi6u cpqshw
22 Jul 20
$5.17M in options / securities to be acquired, sold $5.17M, 1 investor
5:00pm
3
g5tq4so
21 Jul 20
TENAX THERAPEUTICS / Illya Keith Maher ownership change
4:40pm
8-K
2tgsh
20 Jul 20
Tenax Therapeutics Expands Board of Directors with the Appointment
9:00am